Invention Grant
- Patent Title: Hepatitis C virus inhibitors
- Patent Title (中): 丙型肝炎病毒抑制剂
-
Application No.: US13465298Application Date: 2012-05-07
-
Publication No.: US09546160B2Publication Date: 2017-01-17
- Inventor: Qi Chen , Omar D. Lopez , John A. Bender , Gan Wang , Van N. Nguyen , John F. Kadow , Nicholas A. Meanwell , Makonen Belema
- Applicant: Qi Chen , Omar D. Lopez , John A. Bender , Gan Wang , Van N. Nguyen , John F. Kadow , Nicholas A. Meanwell , Makonen Belema
- Applicant Address: US NJ Princeton
- Assignee: Bristol-Myers Squibb Company
- Current Assignee: Bristol-Myers Squibb Company
- Current Assignee Address: US NJ Princeton
- Agent Pamela A. Mingo
- Main IPC: A01N43/50
- IPC: A01N43/50 ; A61K31/415 ; C07D403/14 ; C07D405/14 ; C07D413/14 ; A61K31/4178 ; A61K31/4184 ; A61K31/5377 ; A61K45/06
Abstract:
The present disclosure relates to compounds, compositions and methods for the treatment of Hepatitis C virus (HCV) infection. Also disclosed are pharmaceutical compositions containing such compounds and methods for using these compounds in the treatment of HCV infection.
Public/Granted literature
- US20130121957A1 Hepatitis C Virus Inhibitors Public/Granted day:2013-05-16
Information query
IPC分类:
